Growing community of inventors

Baltimore, MD, United States of America

Ravit Boger

Average Co-Inventor Count = 1.80

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Ravit BogerJuan Jose Marugan (2 patents)Ravit BogerNoel Terrence Southall (2 patents)Ravit BogerJonathan L Vennerstrom (2 patents)Ravit BogerXin Hu (2 patents)Ravit BogerMarc Ferrer (2 patents)Ravit BogerAndres Dulcey Garcia (2 patents)Ravit BogerRavit Boger (6 patents)Juan Jose MaruganJuan Jose Marugan (30 patents)Noel Terrence SouthallNoel Terrence Southall (25 patents)Jonathan L VennerstromJonathan L Vennerstrom (18 patents)Xin HuXin Hu (14 patents)Marc FerrerMarc Ferrer (11 patents)Andres Dulcey GarciaAndres Dulcey Garcia (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Johns Hopkins University (6 from 3,687 patents)

2. University of Nebraska (2 from 924 patents)

3. The United States of America, As Represented by the Secretary, Department of Health and Human Services (1 from 3,539 patents)

4. The United States of America, As Represented by Th (1 from 1 patent)


6 patents:

1. 12208093 - Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

2. 11963945 - Ozonides for treating or preventing virus infections

3. 11253511 - Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

4. 11246854 - Ozonides for treating or preventing virus infections

5. 10610539 - Cardiac glycoside analogs and their use in methods for inhibition of viral infection

6. 9549914 - Treatment of human cytomegalovirus by modulating Wnt

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…